Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy

Exp Neurol. 2014 Jul:257:39-49. doi: 10.1016/j.expneurol.2014.04.014. Epub 2014 Apr 21.

Abstract

The alterations in GABA release have not yet been systematically measured along the natural course of temporal lobe epilepsy. In this work, we analyzed GABA extracellular concentrations (using in vivo microdialysis under basal and high K(+)-evoked conditions) and loss of two GABA interneuron populations (parvalbumin and somatostatin neurons) in the ventral hippocampus at different time-points after pilocarpine-induced status epilepticus in the rat, i.e. during development and progression of epilepsy. We found that (i) during the latent period between the epileptogenic insult, status epilepticus, and the first spontaneous seizure, basal GABA outflow was reduced to about one third of control values while the number of parvalbumin-positive cells was reduced by about 50% and that of somatostatin-positive cells by about 25%; nonetheless, high K(+) stimulation increased extracellular GABA in a proportionally greater manner during latency than under control conditions; (ii) at the time of the first spontaneous seizure (i.e., when the diagnosis of epilepsy is made in humans) this increased responsiveness to stimulation disappeared, i.e. there was no longer any compensation for GABA cell loss; (iii) thereafter, this dysfunction remained constant until a late phase of the disease. These data suggest that a GABAergic hyper-responsiveness can compensate for GABA cell loss and protect from occurrence of seizures during latency, whereas impaired extracellular GABA levels can favor the occurrence of spontaneous recurrent seizures and the maintenance of an epileptic state.

Keywords: GABA release; Parvalbumin; Pilocarpine; Somatostatin; Temporal lobe epilepsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Disease Models, Animal
  • Epilepsy, Temporal Lobe / chemically induced*
  • Epilepsy, Temporal Lobe / pathology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • In Vitro Techniques
  • Male
  • Microdialysis
  • Muscarinic Agonists / toxicity*
  • Neurons / metabolism
  • Parvalbumins / metabolism
  • Pilocarpine / toxicity*
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Channel Blockers / pharmacology
  • Somatostatin / metabolism
  • Tetrodotoxin / pharmacology
  • Time Factors
  • Video Recording
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Muscarinic Agonists
  • Parvalbumins
  • Sodium Channel Blockers
  • Pilocarpine
  • Tetrodotoxin
  • Somatostatin
  • gamma-Aminobutyric Acid
  • Potassium Chloride
  • Calcium